Factors Impacting Definitive Treatment Management in Adolescent and Young Adults (AYAs) with Extremity Sarcomas

A large proportion of extremity soft tissue sarcomas (ESS) occur in the adolescent and young adult (AYA) population, ages 18-39, yet this group is underrepresented in clinical trials. Rare tumors are difficult to study via randomized controlled trials, and the limited data is often extrapolated to AYAs. AYAs present many complex challenges, which affect clinical management. We hypothesized that the National Cancer Database (NCDB) could detect...